Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468975
Status:
COMPLETED
Last Update Posted:
2010-11-01
First Post:
2007-05-02
Brief Title:
A Blinded Study To Examine The Ability Of PF-610355 To Open The Airways In Asthmatic Patients
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase IIA Randomised Double-blind Double Dummy Placebo and Active Controlled 5-Way Cross-over Trial to Examine the Bronchodilator Effects of PF-610355 and to Test for Superiority Versus Placebo in Reversible Asthmatic Patients
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to determine the ability of different doses of PF-610355 to open the airways in asthmatic patients by comparison with placebo and a marketed drug that also opens the airways in asthmatic patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None